Page 2 - Human Monkeypox Virus News Today

UW Medicine researchers are recruiting participants for a Phase 3 clinical trial of a drug to treat the monkeypox virus.

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded its focus to conduct research into COVID-19, today announced the initiation of STOMP (Study of Tecovirimat for Human Monkeypox Virus), or A5418, a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat for the treatment of human monkeypox.

ALPHARETTA, GA / ACCESSWIRE / August 9, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce that heliosDX has launched its testing for the Human Monkeypox Virus through its partner

09.08.2022 - ALPHARETTA, GA / ACCESSWIRE / August 9, 2022 / RushNet, Inc (OTC PINK:RSHN), (the Company) is pleased to announce that heliosDX has launched its testing for the Human Monkeypox Virus through its partner laboratory effective today.With rising ...

Brazilian health authorities Friday confirmed the first death linked to monkeypox in the country: a 41-year-old man, who was already under treatment for other diseases, including cancer, which caused the worsening of his health condition.

/PRNewswire/ -- GT Molecular, a company providing ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels has implemented a...

Maryland's number of presumed monkeypox cases is growing.

Brazilian health authorities Wednesday confirmed the number of confirmed cases of monkeypox nationwide had reached 106, with 75 of them in São Paulo and 20 in Rio de Janeiro.

Three presumed human monkeypox cases have been identified in Maryland, the state health department said Wednesday.

Brazils Health Ministry Monday confirmed the 8th case of monkeypox nationwide. The patient is a 25-year-old man from Maricá, in the metropolitan region of Rio de Janeiro, who does not have a travel record but has been in contact with foreigners.